Saul Kaye

By Saul Kaye As world leaders gather in Davos this week to discuss key issues on the global agenda, cannabis industry leaders will meet to explore the role of cannabis in creating a more sustainable future. This year, two cannabis-related events took place during the days of the World Economic...

The use of psychedelic drugs to treat a host of mental health problems ranging from depression and anxiety, to addiction and PTSD, is gaining new favor in the scientific community. Similar to how attitudes about cannabis have pivoted in recent years, people are now rethinking of how...

Hawthorne Gardening, a unit of Scotts Miracle-Gro Co (NYSE: SMG), and North America’s largest distributor of hydroponic products, is looking to expand its business internationally. Pursuing this objective, the company has signed an agreement with iCAN: Israel-Cannabis to help it infiltrate...

By Saul Kaye, pharmacist and founder of iCAN and CannaTech. With 1,604 reported lung injuries and 34 deaths linked to vaping in the U.S. in recent months, hysteria, finger-pointing and rushed policy changes are threatening the nicotine and cannabis vaping industries.  Public health officials...

It was a tough week for cannabis, but a very good week for psychedelics and hemp. Four major cities took significant steps toward the decriminalization of psilocybin mushrooms and other psychedelic plants. Meanwhile, the United States Department of Agriculture released interim regulations for...

Headquarters (HQ), a Los Angeles-based company set out to solve a fundamental problem for international companies and brands looking to do business in California, has teamed up with Israel-based iCAN Israel-Cannabis to bring innovative cannabis companies from Israel to the US market, particularly...